MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq
November 27, 2023 01:00 ET
|
mdxhealth
COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une...
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
November 27, 2023 01:00 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on...
Global Minimal Residual Disease Testing Market Size To Grow USD 4.38 Billion by 2032 | CAGR of 11.7%
November 20, 2023 06:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The Global Minimal Residual Disease (MRD) Testing Market Size is To Grow from USD 1.45 Billion in 2022 to USD 4.38 Billion by 2032, at a...
Global Liquid Biopsy Market Size To Worth USD 25.24 Billion By 2032 | CAGR of 11.5%
November 15, 2023 05:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Liquid Biopsy Market Size is expected to reach USD 25.24 Billion By 2032, at a CAGR of 11.5% during the forecast period 2022 to...
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference
November 14, 2023 16:00 ET
|
mdxhealth
NEWS RELEASENovember 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 –...
MDxHealth annonce la réalisation de son regroupement d'actions, et la mise à jour des actions et des droits de vote en circulation
November 13, 2023 16:00 ET
|
mdxhealth
COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉEINFORMATION PRIVILÉGIÉE13 NOVEMBRE 2023, 16:00 ET / 22:00 CET MDxHealth annonce la réalisation de son regroupement d'actions, et la mise à jour des...
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
November 13, 2023 16:00 ET
|
mdxhealth
NEWS RELEASE - REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and...
MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023
November 08, 2023 16:00 ET
|
mdxhealth
COMMUNIQUÉ DE PRESSE — INFORMATIONS RÉGLEMENTÉES8 NOVEMBRE 2023, 16 h 00 EDT/22 h 00 CET MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois...
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
November 08, 2023 16:00 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATION8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 IRVINE, CA,...
MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation
November 06, 2023 01:00 ET
|
mdxhealth
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole...